Back A A A Font Size Receive E-mail Alerts Press Releases

MicroPort® Orthopedics Attends the First Edition of the Northeast Region Joint Surgery Summit Forum


Shenyang, China – From 8 June to 9 June, the first edition of the Northeast Region Joint Surgery Summit Forum was held at the Liaoning Province People's Hospital. The forum was jointly held by China Health Promotion Foundation and Orthopedics Online, with Liaoning Province People's Hospital being the organizer and many domestic and foreign well-known experts in the field of joint surgery being present. The forum also built the domestic and foreign orthopedic experts a platform for academic exchanges by means of Master Rostrum, operation live-streaming and sharing typical cases. Shanghai MicroPort® Orthopedics Co., Ltd. ("MicroPort® Orthopedics") attended and presented the Medial-Pivot Knee System, attracting the attentions of many well-known experts in the field.
The forum opened as Professor Bai Xizhuang, who is chairman of the forum and head of the Liaoning Province People's Hospital, called for the efforts of the experts to realize a healthy China and revitalize the development of the northeast Region's orthopedics. As a cooperating corporation with the Liaoning Province People's Hospital for the MicroPort® Joint Replacement Training Center, which is one of the hospital's major medical projects, MicroPort® Orthopedics held a project-unveiling ceremony, which were attended by MicroPort® Scientific Corporation Chief Operation Officer Wang Gude and President of MicroPort® Orthopedics China Weng Zixin. The MicroPort® Joint Replacement Training Center is aimed to train surgeons in the areas such as the skills of joint replacement surgery, speed up the promotion of the concept of Rapid Recovery and benefit more patients by the means of combination of medicine and engineering.
During the Master Rostrum session, Professor Qu Tiebing, who is a standing member of the Chinese Orthopedic Association, deputy head of the Joint Surgery Group of the association and from the Beijing Boai Hospital, delivered a speech on Medial-Pivot Concept and Patients' Satisfaction. Starting from the the Medial-Pivot Concept and combining it with a patient satisfaction survey, Professor Qu Tiebing went to the details of the important meaning of MicroPort® Orthopedics' Medial-Pivot Knee design with regard to the restoration of a normal knee structure. Professor Bai Xizhuang, the chairman of the forum, also delivered a speech together with Mr. Wang Huisheng from Liaoning Province People's Hospital on Clinical Application of Medial-Pivot Knees. Professor Bai Xizhuang and Mr. Wang Huisheng highlighted the highly bionic design of the Medial-Pivot knees and its outstanding performance in the respects of raising prosthesis survivorship and increasing the abrasion resistance of the prosthesis, which caused discussion among the audience. During the surgery live-streaming session, Professor Bai Xizhuang himself demonstrated a total knee replacement operation using MicroPort® Orthopedics EVOLUTION® Medial-Pivot Knee System. He also gave a detailed explanation of the process of the operation, furthering the knowledge of the doctors about Medial-Pivot knee products and the surgery skills. The forum was also live-streamed on Orthopedics Online, attracting nearly 10,000 viewers and creating learning and exchange opportunity for more grassroots doctors.
MicroPort® Orthopedics Medial-Pivot Knee was launched in the US in 1998 with 20 years' clinical history and over 600,000 implantations globally. Several over-15-year long-term clinical follow-up studies and the experiences of the surgeons and patients have already endorsed the importance of the application of media-pivot knees concerning the development of the technology of total knee arthroplasty. A 17-year clinical follow-up study on Medial-Pivot knee products demonstrated extremely high rates for survivorship (98.8%) and patient satisfaction (95%). The presence of MicroPort® Orthopedics and Medial-Pivot Knee products at the first edition of the Northeast Region Joint Surgery Summit Forum is of great importance for MicroPort® Orthopedics's future marketing and promotions in the Northeast region. MicroPort® Orthopedics will also step up the communication and cooperation with surgeons and listen to their clinical demands and suggestions on such specialized academic exchange platforms, before it continues to improve and optimize the product performance that will benefit the patients.

About MicroPort®

MicroPort Scientific Corporation (the "Group") is a leading medical device company with business focusing on innovating, manufacturing, and marketing high-quality and high-end medical devices globally. With a diverse portfolio of products now being used at an average rate of one for every 12 seconds in thousands of major hospitals around the world, the Group maintains world-wide operations in a broad range of business segments including Cardiovascular, Orthopedic, Cardiac Rhythm Management, Electrophysiological, Endovascular, Neurovascular, Surgical, Diabetes Care and Endocrinal Management, and others. MicroPort® is dedicated to becoming a patient oriented global enterprise improve and reshape patient lives through application of innovative science and technology.

For more information, please refer to:

Forward-Looking Statements

Some information contained on this website contains forward-looking statements. These forward-looking statements include, without limitation, those regarding our future financial position, our strategy, plans, objectives, goals and targets, future developments in the markets where we participate or are seeking to participate, and any statements preceded by, followed by or that include the words "believe", "intend", "expect", anticipate", "project", "estimate", "predict", "is confident", "has confidence" and similar expressions are also intended to identify forward-looking statements. Such statements are based upon the current beliefs and expectations of MicroPort®'s management and are subject to significant risks and uncertainties. MicroPort Scientific Corporation undertakes no obligation to update any of the statements. These forward-looking statements are not guarantees of future performance and are subject to risks, uncertainties and other factors that could cause actual future results to differ materially from current expectations include, but are not limited to, general industry and economic conditions, PRC governmental policies and regulations relating to the medical device manufacturing industry, competition in the medical device manufacturing industry, our ability to develop new products and stay abreast of market trends and technological advances, our goals and strategies, our ability to execute strategic acquisitions of, investments in or alliances with other companies and businesses, fluctuations in general economic and business conditions in China.

This document is for information purposes only and does not constitute or form part of any offer or invitation to sell or the solicitation of an offer or invitation to purchase or subscribe for any securities of MicroPort Scientific Corporation, and no part of it shall form the basis of, or be relied upon in connection with, any agreement, arrangement, contract, commitment or investment decision in relation thereto whatsoever.

All rights reserved.
Copyright © 1998-2019 MicroPort Scientific Corporation

Leanne Li
Board Secretary and Vice President of Corporate General Affairs
MicroPort Scientific Corporation
Tel: (86)(21) 38954600-6953


[Prev]:Firehawk® Presented at the 15th Malaysian Cardiovascular Interventional Symposium with Live Transmission (MYLIVE2018)
[Next]:Shanghai MicroPort Medical (Group) Co., Ltd. Won A Patent Right Lawsuit Against NewMed Medical Co., Ltd.